S Matsuoka Selected Research

S Matsuoka Research Topics

Disease

2	Neoplasms (Cancer) 01/2017 - 01/2010
2	Dyspnea (Shortness of Breath) 01/2007 - 07/2000
2	Hemorrhage 01/2005 - 07/2001
2	Pneumonia (Pneumonitis) 01/2005 - 05/2000
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2019
1	Hematoma 01/2018
1	Ulcer 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Leiomyoma (Uterine Fibroids) 01/2017
1	Bites and Stings (Sting) 01/2015
1	Glomerulonephritis 07/2014
1	Systemic Vasculitis 07/2014
1	Serous Cystadenocarcinoma 01/2010
1	Endometrial Neoplasms (Endometrial Cancer) 01/2010
1	Hemoperitoneum 01/2009
1	Cornual Pregnancy 01/2009
1	Infections 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2007
1	Dermatomyositis (Dermatopolymyositis) 01/2007
1	Acute Lung Injury 01/2005
1	Pulmonary Sarcoidosis 12/2001
1	Lung Neoplasms (Lung Cancer) 07/2001
1	Hemorrhagic Shock 07/2001
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2001
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 02/2001
1	Complete atrioventricular septal defect 10/2000
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 10/2000
1	Hypertension (High Blood Pressure) 10/2000
1	Vascular Diseases (Vascular Disease) 10/2000
1	Multiple System Atrophy 07/2000
1	Autoimmune Hepatitis 05/2000
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2000
1	Pancytopenia 05/2000
1	Retinitis 04/2000
1	Gastroenteritis 04/2000
1	Dementia (Dementias) 02/2000
1	AIDS Dementia Complex 02/2000
1	Opportunistic Infections (Opportunistic Infection) 02/2000

Drug/Important Bio-Agent (IBA)

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019 - 01/2007
2	Peroxidase (Myeloperoxidase)IBA 07/2014 - 01/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2019
1	Busulfan (Busulfex)FDA Link 04/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2019
1	fludarabineIBA 04/2019
1	AntigensIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Gemcitabine FDA Link 01/2017
1	Antivenins (Antivenoms)IBA 01/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2014
1	MesothelinIBA 01/2010
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2010
1	AntibodiesIBA 01/2007
1	Oxygen (Dioxygen)IBA 01/2007
1	Tetradecanoylphorbol AcetateIBA 01/2005
1	SodiumIBA 01/2005
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2005
1	EnzymesIBA 01/2005
1	sivelestatIBA 01/2005
1	Secretory Proteinase Inhibitory ProteinsIBA 01/2005
1	gallium citrateIBA 12/2001
1	Phosphotransferases (Kinase)IBA 07/2001
1	technetium Tc 99m DTPA-galactosyl-human serum albuminIBA 02/2001
1	technetium Tc 99m pyrrolidino-methyltetracyclineIBA 02/2001
1	Carbon DioxideIBA 10/2000
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 07/2000
1	Indium-111IBA 05/2000
1	ChloridesIBA 05/2000
1	RNA (Ribonucleic Acid)IBA 02/2000
1	NucleosidesIBA 02/2000
1	Reverse Transcriptase InhibitorsIBA 02/2000
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2000

Therapy/Procedure

4	Therapeutics 01/2007 - 02/2000
2	Laparotomy 01/2017 - 01/2009
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2019
1	Intravenous Administration 04/2019
1	Oral Administration 04/2019
1	Epidural Analgesia 01/2018
1	Adjuvant Chemotherapy 01/2017
1	Uterine Myomectomy 01/2017
1	Hysterectomy 01/2009
1	Catheters 07/2001
1	Resuscitation 07/2001
1	Autologous Transplantation 02/2001
1	Flowmeters 10/2000
1	Tracheostomy 07/2000
1	Aftercare (After-Treatment) 05/2000
1	Highly Active Antiretroviral Therapy (HAART) 02/2000